• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print

Corporate Spotlight

Race Oncology Ltd (RAC) is a specialty pharmaceutical company. Its business model is to pursue later stage drug assets, principally in the cancer field. Its important asset is a chemotherapy drug, called Bisantrene. Race Oncology is rediscovering Bisantrene.
View the full Corporate Spotlight arrow Created with Sketch.

director sees
refresh Created with Sketch. REFRESH
Last update - 12.22pm 19/04/2019 (20 minute delay) ?
Open 7.4¢   Day High 7.4¢   Day Low 7.4¢
Daily Volume 29049
Bids   Sellers
Number Price Volume   Number Price Volume
1 7.4¢ 14766   1 7.5¢ 96978

Directors & Senior Management

Mr. Peter Molloy Chief Executive Officer
Dr. William J. Garner Chairman of the Board
Mr. Peter Molloy Chief Executive Officer
Dr. Samar Al-Behaisi Chief Medical Officer and Vice President - Medical Affairs
Mr. Peter Gordon Webse Company Secretary
Mr. Chris Ntoumenopoulos Director
Mr. John Cullity Non-Executive Director

Data source: Thomson Reuters

(20min delay)
Mkt cap ! $6.542M
Open High Low Value Volume
7.4¢ 7.4¢ 7.4¢ $2.15K 29.04K

Buyers (Bids)

No. Vol. Price($)
1 14766 7.4¢

Sellers (Offers)

Price($) Vol. No.
7.5¢ 96978 1
View Market Depth
Last update - 16.10pm 19/04/2019 (20 minute delay) ?
-0.001 ( 0.00 %)
Open High Low Volume
7.3¢ 7.3¢ 7.3¢ 6185
Last updated 12.22pm 19/04/2019 (live) ?
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.